Revenue - Revenue from Customers as a Percentage of Total Product Revenue, Net (Details) - Gross product revenue - Customer	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
BioRidge Pharma, LLC
Disaggregation of Revenue [Line Items]
Concentration risk (as percent)	39.90%	17.60%
AmerisourceBergen Drug Corporation
Disaggregation of Revenue [Line Items]
Concentration risk (as percent)	18.30%	21.60%
Cardinal Health
Disaggregation of Revenue [Line Items]
Concentration risk (as percent)	16.20%	22.20%
McKesson Corporation
Disaggregation of Revenue [Line Items]
Concentration risk (as percent)	13.50%	20.80%